PI3KCA mutations and/or PTEN loss in Her2-positive breast carcinomas treated with trastuzumab are not related to resistance to anti-Her2 therapy.
| Image |  |
|---|---|
| Description | scientific article published on 29 June 2012 |
| Author/s |
author: Claudio Eccher |
| Publication date | June 29, 2012 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |